Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Mar 23;33(4):473-477.
doi: 10.5606/ArchRheumatol.2018.6741. eCollection 2018 Dec.

The Role of Familial Mediterranean Fever Gene Mutation in Treatment of Infantile Colitis With Resistant Perianal Fistula

Affiliations
Case Reports

The Role of Familial Mediterranean Fever Gene Mutation in Treatment of Infantile Colitis With Resistant Perianal Fistula

Maşallah Baran et al. Arch Rheumatol. .

Abstract

Symptoms of infantile inflammatory bowel disease (I-IBD) can be life-threatening and associated with poor prognosis. The presence of Mediterranean fever (MEFV) gene mutations play an important role in treatment of I-IBD. In this article, we describe a case of I-IBD with a resistant fistula, in which remission occurred following colchicine therapy. The patient was a six-month-girl with complaints of bloody diarrhea and a perianal abscess of three months duration. Laboratory tests revealed elevated inflammatory parameters, hypoalbuminemia, and anemia. Results of repeated viral, bacterial and parasitic analyses were negative. Endoscopic and histopathological examinations confirmed a diagnosis of I-IBD. Although diarrhea episodes decreased following intensive conventional treatment with immunosuppressive therapy and anti-tumor necrosis factor, the perianal abscess and fistula did not resolve. Molecular genetic analysis to identify causes of infantile disease revealed the MEFV gene mutation. Thus, colchicine was added to the treatment regimen. Following treatment with colchicine, defecation returned to normal, and the fistula resolved. The MEFV gene mutation should be investigated in children with infantile colitis and resistant fistulas, particularly in Mediterranean countries. In patients with infantile colitis who have the MEFV gene mutation, colchicine treatment may be an alternative to intensive immunosuppressive therapy.

Keywords: Colchicine; infantile colitis; perianal fistula.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.

Figures

Figure 1
Figure 1. View of perianal fistula and endoscopic image of colon concurrently. (a) A perianal abscess with extra sphincteric fistula and moderate colitis, at time of added colchicine therapy. (b) Healing of perianal lesion and normal mucosal appearance of colon one year later.
Figure 2
Figure 2. (a) Histopathologic appearance of colon at admission time. (b) At start of colchicine therapy. (c) After one year of colchicine therapy. (a) Mixed inflammatory infiltrate in lamina propria, cryptitis, and crypt destruction (H-E¥400). (b) Mild crypt distortion and cryptitis (H-E¥200). (c) Edema in lamina propria, there is no cryptitis (H-E¥200).

Similar articles

Cited by

References

    1. Uhlig HH, Schwerd T, Koletzko S, Shah N, Kammermeier J, Elkadri A. COLORS in IBD Study Group and NEOPICS. The Diagnostic Approach to Monogenic Very Early Onset Inflammatory Bowel Disease. Gastroenterology. 2014;147:990–1007. - PMC - PubMed
    1. Szymanska E, Szymanska S, Szczepanski M, Landowski P, Czaja-Bulsa G, Jarocka-Cyrta E, et al. Demographic characteristics of children with early clinical manifestation of inflammatory bowel disease. Prz Gastroenterol. 2016;11:14–17. - PMC - PubMed
    1. Glocker EO, Kotlarz D, Boztug K, Gertz EM, Schäffer AA, Noyan F, et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med. 2009;361:2033–2045. - PMC - PubMed
    1. Sari S, Egritas O, Dalgic B. The familial Mediterranean fever (MEFV) gene may be a modifier factor of inflammatory bowel disease in infancy. Eur J Pediatr. 2008;167:391–393. - PubMed
    1. Egritas O, Dalgic B. Infantile Colitis as a Novel Presentation of Familial Mediterranean Fever Responding to Colchicine Therapy. J Pediatr Gastroenterol Nutr. 2011;53:102–105. - PubMed

Publication types

LinkOut - more resources